4DMedical Limited logo

4DMedical Limited (FDMDF)

Market Closed
5 Dec, 20:00
OTC PINK OTC PINK
$
0. 87
0
0%
$
106.09M Market Cap
- P/E Ratio
0% Div Yield
0 Volume
-0.07 Eps
$ 0.87
Previous Close
Day Range
0.87 0.87
Year Range
0.16 1.64
Want to track FDMDF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 85 days

Summary

FDMDF closed yesterday higher at $0.87, an increase of 0% from Thursday's close, completing a monthly decrease of -22.31% or $0.25. Over the past 12 months, FDMDF stock gained 135.16%.
FDMDF is not paying dividends to its shareholders.
The last earnings report, released on Aug 28, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Mar 02, 2026.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).

FDMDF Chart

4DMedical Limited (FDMDF) Discusses Expansion of Distribution Agreement for CT:VQ Non-Contrast Lung Imaging Solution Transcript

4DMedical Limited (FDMDF) Discusses Expansion of Distribution Agreement for CT:VQ Non-Contrast Lung Imaging Solution Transcript

4DMedical Limited (FDMDF) Discusses Expansion of Distribution Agreement for CT:VQ Non-Contrast Lung Imaging Solution Transcript

Seekingalpha | 3 days ago
4DMedical Limited - Special Call

4DMedical Limited - Special Call

4DMedical Limited - Special Call Company Participants Andreas Fouras - Founder, MD, CEO & Director Conference Call Participants Thomas Godfrey - Ord Minnett Limited, Research Division Kyle Hogarth Presentation Thomas Godfrey Ord Minnett Limited, Research Division Fantastic. I think we're live.

Seekingalpha | 2 months ago

4DMedical Limited (FDMDF) FAQ

What is the stock price today?

The current price is $0.87.

On which exchange is it traded?

4DMedical Limited is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is FDMDF.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 106.09M.

When is the next earnings date?

The next earnings report will release on Mar 02, 2026.

Has 4DMedical Limited ever had a stock split?

No, there has never been a stock split.

4DMedical Limited Profile

- Industry
- Sector
Dr. Andreas Fouras M.A.I.C.D., Ph.D. CEO
OTC PINK Exchange
AU0000095416 ISIN
AU Country
145 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

4DMedical Limited is a forefront medical technology company with operational bases in Australia and the United States. Established in 2012 and headquartered in Carlton, Australia, the company specializes in the commercialization of its proprietary four-dimensional lung imaging technology, known as XV Technology. This innovative approach aims to revolutionize the diagnosis and management of pulmonary conditions by providing detailed and dynamic images of lung function. Additionally, 4DMedical offers its products and services through a software as a service (SaaS) delivery model, striving to enhance accessibility and efficiency for healthcare professionals and researchers worldwide.

Products and Services

  • XV Technology

    This is 4DMedical's flagship four-dimensional lung imaging technology, designed to offer unprecedented insights into lung function and ventilation dynamics. By capturing detailed, time-sequenced images of the lungs as they fill and empty of air, this advanced imaging solution provides clinicians with a deeper understanding of pulmonary conditions, facilitating more accurate diagnoses and personalized treatment plans.

  • Software as a Service (SaaS) Delivery Model

    4DMedical capitalizes on cloud computing to offer its XV lungs ventilation analysis software and other applications as a service over the internet. This model eliminates the need for extensive hardware by clients, reduces upfront costs, and provides flexibility and scalability to accommodate varying organizational requirements.

  • XV Lungs Ventilation Analysis Software

    A cornerstone of 4DMedical’s offering, this software enables the detailed analysis of lung function utilizing the data generated by XV Technology. It provides healthcare professionals with a comprehensive suite of tools for assessing ventilation heterogeneity and other functional parameters critical for diagnosing and managing pulmonary diseases.

  • Permetium

    This preclinical imaging system is specifically designed to quantify regional changes in pulmonary function. Permetium is aimed at researchers working on respiratory conditions, providing detailed images and functional insights that can dramatically enhance the understanding of disease mechanisms and the effects of therapeutic interventions.

  • AccuVent 200

    A sophisticated small animal ventilator, AccuVent 200 complements 4DMedical's suite of pulmonary analysis tools by facilitating precise ventilation control during imaging procedures. This equipment is crucial for preclinical studies that require detailed and consistent respiratory management to ensure the accuracy of pulmonary function assessments.

Contact Information

Address: Melbourne Connect
Phone: 61 3 9545 5940